Science and Enterprise

Search results for: “law”

  • DuPont Expanding Iowa Agriculture R&D Center

    DuPont Corporation says it will add a $40 million plant genetics research center to its current facilities in Johnston, Iowa. The 200,000 square foot center is expected to add some 400 jobs. The new facility will be part of DuPont’s Pioneer Hi-Bred business, a subsidiary developing seeds through plant genetics. Johnston is located northwest of…

  • Graphene Materials Faster, Cheaper at Cooling Electronics

    A materials scientist at North Carolina State University in Durham has created a new way of cooling high-temperature electronic devices with composites made of graphene. The work of Jag Kasichainula, a professor of materials science and engineering at NC State, appears in the journal Metallurgical and Materials Transactions B (paid subscription required). Graphene is a…

  • Unilever Launches Open Innovation Initiative

    The consumer goods manufacturer Unilever unveiled today its open innovation program seeking ideas for new products and technologies from the public at large. The initiative is managed by the online intellectual property marketplace yet2.com. Unilever’s program is structured around a set of issues or problems for which it seeks collaborators to find solutions. The opening…

  • Graphene Electrodes Developed for Supercapacitors

    Researchers at University of California in Los Angeles have developed electrodes for supercapacitors, energy storage devices that charge and discharge faster than batteries, using a one-atom-thick layer of carbon called graphene. Their findings appear in his week’s issue of the journal Science (paid subscription required). In addition to faster charging and discharging, supercapacitors store substantially…

  • Tracking Antibiotic Use Reaps Big Hospital Cost Savings

    Analysis of a program to monitor unnecessary use of antibiotics shows the program saved one big-city hospital millions of dollars without compromising patient care. That’s the conclusion of a study done by researchers at University of Maryland Medical Center (UMMC) in Baltimore, where, the study was conducted, as well as colleagues from hospitals in Wilmington,…

  • Traffic Intersection Study Pinpoints Stoplight Danger Zone

    Engineers at Oregon State University in Corvallis have identified more about the dangers faced by drivers and pedestrians alike when traffic lights turn yellow at intersections. The findings of transportation engineering professor David Hurwitz and colleagues from OSU and University of Massachusetts in Amherst appear in this month’s issue of the journal Transportation Research Part…

  • Maryland Universities to Partner on Biotech, Tech Transfer

    University of Maryland campuses in Baltimore (UMB) and College Park (UMCP) have agreed on a plan to collaborate on new or combined biotechnology, public health, and commercialization programs, as well as encourage joint research, faculty appointments, and grant submissions. The state’s university board of regents today approved the partnership called University of Maryland: MPowering the…

  • Patent Issued for Protein-Engineered Flu Vaccine Technology

    Fraunhofer USA in Newark, Delaware has been assigned a U.S. patent for its technology that binds proteins with antigens to fight influenza. The Patent and Trademark Office awarded patent 8,124,103 on 28 February to three inventors, including Vidadi Yusibov, executive director of Fraunhofer USA. Yusibov also serves as the chief scientific officer of iBio Inc.,…

  • Cell Phone User Locations Open to Hackers via Networks

    Computer scientists at University of Minnesota in Minneapolis have discovered a vulnerability in cellular networks that can allow hackers to follow individual cell phone users without their knowledge. Ph.D. candidate Denis Foo Kune, with fellow student John Koelndorfer and professors Nick Hopper and Yongdae Kim presented their findings earlier this month at the Network &…

  • FDA Releases Draft Biosimilars Guidance

    The Food and Drug Administration has issued three guidance documents in draft on biosimilar therapeutics — functional equivalents of biologic therapies — that the agency says will soon be open for public comment. Guidance documents offer insights into the current thinking of FDA on key scientific and regulatory topics, and are not binding on the…